Entrada Therapeutics Reports Second Quarter 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to Entrada Therapeutics Reports Second Quarter 2024 Financial Results
(NASDAQ: TRDA) Delayed: 6.16 -0.06 (0.96%)
Previous Close $6.22    52 Week High $ 
Open $6.23    52 Week Low $ 
Day High $6.25    P/E N/A 
Day Low $6.01    EPS $ 
Volume 374,038